Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Short Interest Up 412.2% in January

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) was the recipient of a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 447,700 shares, a growth of 412.2% from the December 31st total of 87,400 shares. Based on an average trading volume of 2,936,800 shares, the short-interest ratio is currently 0.2 days.

Bayer Aktiengesellschaft Price Performance

OTCMKTS BAYRY traded down $0.07 on Friday, hitting $5.64. The company had a trading volume of 1,283,851 shares, compared to its average volume of 1,182,263. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.32 and a quick ratio of 0.81. The company has a market capitalization of $22.16 billion, a PE ratio of -21.69 and a beta of 1.02. Bayer Aktiengesellschaft has a 12-month low of $4.79 and a 12-month high of $8.58. The company’s fifty day moving average price is $5.17 and its 200-day moving average price is $6.54.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last issued its quarterly earnings results on Tuesday, November 12th. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.17 by ($0.10). The firm had revenue of $10.96 billion for the quarter. Bayer Aktiengesellschaft had a positive return on equity of 16.90% and a negative net margin of 2.02%. As a group, analysts predict that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current year.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.